G6 Clinical activity observed in a phase I dose escalation trial of an oral c-met and ALK inhibitor, PF-02341066 (original ) (raw )Adjuvant simultaneous integrated boost IMRT for patients with intermediate- and high-risk head and neck cancer: Outcome, toxicities and patterns of failure
Jan-Dirk Raguse
Oral Oncology, 2014
View PDFchevron_right
Final results of the EORTC 18871/DKG 80-1 randomised phase III trial
Eva-Bettina Brocker
European Journal of Cancer, 2004
View PDFchevron_right
The Treatment Outcome and Radiation-Induced Toxicity for Patients with Head and Neck Carcinoma in the IMRT Era: A Systematic Review with Dosimetric and Clinical Parameters
Stella Thalassinou , John Kouvaris , Christos Antypas
BioMed Research International, 2013
View PDFchevron_right
Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experience
Dirk Van Gestel , Dirk Schrijvers
British Journal of Radiology, 2011
View PDFchevron_right
Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225
Mona Sabra
2009
View PDFchevron_right
Intensity Modulated Radiotherapy (IMRT) in the Management of Locally Advanced Oropharyngeal Squamous Cell Carcinomata (SCC): Disease Control and Functional Outcome using the Therapy Outcome Measure (TOM) Score. A Report from a Single UK Institution
Kent Yip
Head & Neck Oncology, 2010
View PDFchevron_right
A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer
Catharine Clark
Radiotherapy and Oncology, 2007
View PDFchevron_right
Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: Preliminary correlations with local control and overall survival
J.-p. Pignon
International Journal of Radiation Oncology*Biology*Physics, 1993
View PDFchevron_right
Challenges in the re-irradiation of locally advanced head and neck cancers: outcomes and toxicities
Naomi Schechter
Journal of Radiation Oncology, 2019
View PDFchevron_right
Comparison of Radiation-Induced Secondary Malignancy Risk Between Sequential and Simultaneous Integrated Boost for the Treatment of Nasopharyngeal Carcinoma: Intensity-Modulated Radiotherapy versus Volumetric-Modulated Arc Therapy
Adnan Yoney
Cancer Management and Research, 2020
View PDFchevron_right
Simultaneous integrated boost-intensity-modulated radiotherapy in head and neck cancer
Marta Casati
2013
View PDFchevron_right
Postoperative IMRT in head and neck cancer
Gabriela Studer
2006
View PDFchevron_right
Clinical outcomes and Toxicity profile with IMRT or Brachytherapy boost in oropharyngeal malignancies: A Randomized, open label study
PRATIBHA BAUSKAR
International Journal of Radiation Oncology*Biology*Physics, 2020
View PDFchevron_right
Head and neck cancer: improving outcomes with a multidisciplinary approach
Marco Merlano
Cancer Management and Research
View PDFchevron_right
Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy
Pramod Sharma
Annals of Oncology, 2012
View PDFchevron_right
Whole-Field Sequential Intensity–Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma
Bharat Mittal
American Journal of Clinical Oncology, 2015
View PDFchevron_right
Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer
Hanna Mortensen , Lena Specht
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2012
View PDFchevron_right
When is definitive radiotherapy the preferred treatment for head and neck squamous cell carcinoma?
Avraham Eisbruch
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2015
View PDFchevron_right
Toxicity, Swallow Function, and Quality of life on MC1273, a Phase 2 Study of Dose De-escalation for Adjuvant Chemoradiation in HPV+ Oropharynx Squamous Cell Carcinoma
Robert Foote
International Journal of Radiation Oncology Biology Physics, 2018
View PDFchevron_right
Are We Influencing Outcome in Oropharynx Cancer With Intensity-Modulated Radiotherapy? An Inter-Era Comparison
Karen Chura
International Journal of Radiation Oncology Biology Physics, 2007
View PDFchevron_right
Head and neck cancer emerging strategies: advances and new challenges
Gilberto Castro
Current Opinion in Oncology, 2009
View PDFchevron_right
Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience
Ricky Kong
International Journal of Radiation Oncology Biology Physics, 2004
View PDFchevron_right
A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study
Nigel Spry
Radiotherapy and Oncology, 2001
View PDFchevron_right
A randomized prospective study comparing acute toxicity, compliance and objective response rate between simultaneous integrated boost and sequential intensity-modulated radiotherapy for locally advanced head and neck cancer
Lalit Mohan Sharma
Radiation Oncology Journal
View PDFchevron_right
Acute and late normal tissue reactions in the DAHANCA 6&7 randomized trial with accelerated radiotherapy for head and neck cancer
Lena Specht
International Journal of Radiation Oncology*Biology*Physics, 2003
View PDFchevron_right
IMRT in oral cavity cancer
Gabriela Studer
Radiation Oncology, 2007
View PDFchevron_right
Radiobiological evaluation of intensity modulated radiation therapy treatments of patients with head and neck cancer: A dual-institutional study
Ganesh Narayanasamy
Journal of Medical Physics, 2015
View PDFchevron_right
A Systematic Overview of Radiation Therapy Effects in Head and Neck Cancer
Eva Cavallin-ståhl
Acta Oncologica, 2003
View PDFchevron_right